ArticlePolymers2026
A Bioactive 3D-Bioprinted AuNC@DHLA/GelMA Hydrogel Containing Skin Cells Promotes Burn Wound Healing and Tissue Regeneration.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Severe burn injuries are often associated with excessive and prolonged inflammation, resulting in delayed wound healing and poor tissue regeneration. Accordingly, the development of effective skin substitutes capable of modulating inflammation and promoting tissue repair remains a critical challenge in regenerative medicine. Gelatin methacryloyl (GelMA) has emerged as a promising biomaterial for tissue engineering applications. Moreover, dihydrolipoic acid-modified gold nanoclusters (AuNC@DHLA) have demonstrated anti-inflammatory and regenerative-promoting effects. In this study, we fabricated a bioactive tissue-engineered skin construct by incorporating AuNC@DHLA, fibroblasts, and keratinocytes into a 3D-bioprinted GelMA hydrogel scaffold. The therapeutic efficacy of the cell-laden AuNC@DHLA/GelMA scaffold was evaluated using a murine burn wound model. Furthermore, RNA sequencing was further conducted to explore the molecular mechanisms underlying wound repair, and the findings were subsequently validated by immunohistochemistry. The results demonstrated that the scaffold significantly attenuated local inflammatory responses and accelerated burn wound closure compared with control treatments. Transcriptomic analysis revealed the modulation of inflammation-related and tissue regeneration-associated pathways, which was further confirmed by immunohistochemical analyses. Collectively, these findings indicate that the AuNC@DHLA/GelMA bioengineered skin substitute promotes burn wound healing by regulating the inflammatory microenvironment and enhancing tissue regeneration. This strategy represents a promising therapeutic approach for the treatment of severe burn injuries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.